2026-06-22T12:19:24-04:00 2025-12-31 843085028 BRYTEBRIDGE CONSULTING LLC 7021 UNIVERSITY BLVD WINTER PARK FL 327926719 990 2025-03-18 333912998 THE MYT1L PROJECT FOUNDATION INC MYT1 7186821310 418 BROADWAY ALBANY NY 12207 BRITTANY GARY TREASURER/DIRECTOR 7186821310 2026-06-22 true ANDREW D PAYNE EA P02188892 8778579002 2026-06-22 2025 2025-03-06 01:10:19Z X ELIZABETH WOOD 418 BROADWAY STE N ALBANY NY 12207 241518 false X HTTPS://MYT1LPROJECT.ORG X 2025 NY THE MYT1L PROJECT IS A PARENT-LED, SCIENTIST-SUPPORTED FOUNDATION ESTABLISHED IN 2025 TO ADVANCE RESEARCH INTO EVIDENCE-BASED INTERVENTIONS FOR MYT1L NEURODEVELOPMENTAL SYNDROME, A RARE GENETIC CONDITION MARKED BY DEVELOPMENTAL DISABILITIES, BEHAVIORAL CHALLENGES, AND OBESITY. OUR MISSION IS TO FOSTER COLLABORATION BETWEEN FAMILIES, PATIENTS, AND RESEARCHERS TO DEVELOP EFFECTIVE TREATMENTS THAT IMPROVE THE QUALITY OF LIFE FOR INDIVIDUALS AND THEIR FAMILIES. 8 8 0 8 0 241517 0 1 0 241518 0 0 0 0 0 2307 2307 239211 239211 0 239211 X THE MYT1L PROJECT IS A PARENT-LED, SCIENTIST-SUPPORTED FOUNDATION ESTABLISHED IN 2025 TO ADVANCE RESEARCH INTO EVIDENCE-BASED INTERVENTIONS FOR MYT1L NEURODEVELOPMENTAL SYNDROME, A RARE GENETIC CONDITION MARKED BY DEVELOPMENTAL DISABILITIES, BEHAVIORAL CHALLENGES, AND OBESITY. OUR MISSION IS TO FOSTER COLLABORATION BETWEEN FAMILIES, PATIENTS, AND RESEARCHERS TO DEVELOP EFFECTIVE TREATMENTS THAT IMPROVE THE QUALITY OF LIFE FOR INDIVIDUALS AND THEIR FAMILIES. false false 183 ASO DISCOVERY - THE ORGANIZATION IS FUNDING RESEARCH AND OTHER SCIENTIFIC WORK THAT AIMS TO IDENTIFY A SPECIFIC ANTISENSE OLIGONUCLEOTIDE (ASO) MOLECULE THAT COULD CONTRIBUTE TO THE DEVELOPMENT OF A THERAPY FOR MYT1L NEURODEVELOPMENTAL DISORDER. SCIENTIFIC AND FAMILY MEETING - THE ORGANIZATION COORDINATES AND HOSTS SCIENTISTS INVOLVED IN FURTHERING THE UNDERSTANDING OF THE FUNCTION OF THE MYT1L GENE AND THE PATHOGENESIS OF MYT1L NEURODEVELOPMENTAL SYNDROME (MNS) ALONG WITH FAMILIES AFFECTED BY MNS AT AN ANNUAL MEETING. 183 true true false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false 0 0 false 0 false false false false false false false false X 8 8 false false false false false false false true true false false true true true true true false false false false NY X BRITTANY GARY 7186821310 418 BROADWAY STE N ALBANY NY 12207 X MATTHEW BATCHELDOR SECRETARY/DI 1.00 X X 0 0 0 KATIE CLAWSON DIRECTOR 1.00 X 0 0 0 ALLISON COSHENET DIRECTOR 1.00 X 0 0 0 AMANDA ELEY DIRECTOR 1.00 X 0 0 0 FARAH FEHRING DIRECTOR 1.00 X 0 0 0 BRITTANY GARY TREASURER/DI 1.00 X X 0 0 0 KATE KRATOFIL VP/DIRECTOR 1.00 X X 0 0 0 ELIZABETH WOOD PRESIDENT/DI 1.00 X X 0 0 0 false false false 241517 241517 1 1 241518 1 183 183 2124 2124 2307 183 2124 0 239211 0 239211 0 0 X 239211 0 239211 0 239211 239211 X false false false X 241517 241517 241517 241517 11143 11143 11143 11143 230374 1 1 1 1 241518 241518 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990 - ORGANIZATION'S MISSION THE MYT1L PROJECT IS A PARENT-LED, SCIENTIST-SUPPORTED FOUNDATION ESTABLISHED IN 2025 TO ADVANCE RESEARCH INTO EVIDENCE-BASED INTERVENTIONS FOR MYT1L NEURODEVELOPMENTAL SYNDROME, A RARE GENETIC CONDITION MARKED BY DEVELOPMENTAL DISABILITIES, BEHAVIORAL CHALLENGES, AND OBESITY. OUR MISSION IS TO FOSTER COLLABORATION BETWEEN FAMILIES, PATIENTS, AND RESEARCHERS TO DEVELOP EFFECTIVE TREATMENTS THAT IMPROVE THE QUALITY OF LIFE FOR INDIVIDUALS AND THEIR FAMILIES. FORM 990, PAGE 6, PART VI, LINE 11B OFFICERS REVIEW THE 990 BEFORE IT IS FILED. FORM 990, PAGE 6, PART VI, LINE 12C THE ORGANIZATION ENFORCED COMPLIANCE WITH ITS CONFLICT OF INTEREST POLICY BY REVIEWING IT PERIODICALLY AT BOARD MEETINGS. FORM 990, PAGE 6, PART VI, LINE 19 NO DOCUMENTS AVAILABLE TO THE PUBLIC